Key facts
- Notable investors include Hefei Hi-Tech VC, Hefei Comprehensive National Science Center Big Health Research Institute, Feixi County Industrial Park Investment Holding (Group), Miracle Light Venture, Ningbo Pancheng Zhixin Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Nova-MS Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Nova-MS Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nova-MS Biotech
Manufacturer of advanced mass spectrometry diagnostics equipment intended to improve medical screening and disease detection. The company specializes in mass spectrometry detection and precision medical solutions, enabling advancements in diagnostic accuracy and personalized healthcare for conditions like Alzheimer's, bladder cancer, and hormone-related disorders.
- Sector
- Healthcare
- HQ
- Hefei, China
- Founded
- 2020
- Website
- novamsbio.com/
- Ownership
- Privately Held (backing)
Nova-MS Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nova-MS Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nova-MS Biotech in its N-PORT filings yet. We sweep new filings monthly.